Molecular Oncology is an open access journal that primarily publishes Research Articles from the fields of basic, translational, and clinical cancer research. We also consider Review Articles, Commentaries, and Policy Papers discussing emerging concepts in cancer research, cancer diagnosis, prevention and care. Manuscripts are handled by a team of dedicated academic Section Editors under a transparent peer review scheme. Molecular Oncology is owned by the Federation of European Biochemical Societies (FEBS). FEBS is a not-for-profit organization. Any income from the journal will be used to support scientists through fellowships, courses, travel grants, prizes, and other FEBS initiatives.